Petah Tikva, Israel (OTE) – Isotopia Molecular Imaging, in
partnership with Cardirad , proudly
announces the launch of Isoprotrace®—an advanced Gallium-68
Gozetotide preparation kit for prostate cancer imaging—in Sweden and
Denmark.
The introduction of Isoprotrace® into these Nordic markets marks
a significant step forward in expanding access to precision
diagnostic tools for prostate cancer. Isoprotrace® is a ready-to-use,
multi-dose kit designed for the efficient preparation of Gallium-68
Gozetotide solution for intravenous injection, enabling healthcare
professionals to enhance the detection and management of prostate
cancer through PET imaging. It is indicated for primary staging of
high-risk prostate cancer patients prior to curative therapy, as well
as for those with suspected recurrence based on elevated PSA levels.
Cardirad, a leading distributor of healthcare products in the
region, will ensure that Isoprotrace® is readily accessible to
medical facilities across Sweden and Denmark. „We are proud to
partner with Isotopia to bring this innovative diagnostic solution to
clinicians and patients in the Nordic region,“ said John Storbjörk,
President at Cardirad. „Isoprotrace® provides healthcare
professionals with a valuable tool to improve diagnostic accuracy and
optimize patient care in prostate cancer.“
Tzachi Levy, General Manager of Isotopia’s aseptic plant,
commented, „The launch of Isoprotrace® in Sweden and Denmark
underscores our commitment to advancing prostate cancer care
globally. By working with Cardirad, we are ensuring that patients and
clinicians in the Nordics benefit from state-of-the-art diagnostic
technology.“
Isoprotrace® has already received marketing authorization and is
available in the Netherlands, UK, and Germany, and is expected to be
available soon in more EU countries, reflecting Isotopia’s robust
supply chain and dedication to expanding patient access to innovative
radiopharmaceuticals
For more information about Isoprotrace®, including product
details and availability in Sweden and Denmark, please contact
Cardirad at [email protected] or Isotopia’s official product page
https://isotopia-global.com/isoprotrace/
About Isotopia Molecular Imaging
Isotopia Molecular Imaging is a global leader in
radiopharmaceutical development, specializing in theranostic
solutions that enhance diagnostic accuracy and treatment efficacy.
With a steadfast commitment to innovation and patient-centred care,
Isotopia delivers reliable, high-quality radiopharmaceuticals to
healthcare providers worldwide.
https://isotopia-global.com/isoprotrace/
About Cardirad Nordic
Cardirad Nordic distributes advanced healthcare products across
the Nordic and Baltic regions, supporting healthcare providers with
access to leading medical technologies.
https://cardirad.com/cardirad-nordic
Digital press kit: http://www.ots.at/pressemappe/PR171734/aom
